Colon

HCEC-1CT

Evercyte ́s human colon epithelial cell line HCEC-1CT can be grown without limitations while maintaining expression of cell type specific markers and functions. Therefore, these cells are useful for setting up in vitro bioassays to study drug / nutrient absorption and to assess drug-induced toxicity on the large intestine barrier. Additionally, the cells are valuable for modelling cancer progression in vitro.

General information

Cat#: CHT-039-0229

Organism: homo sapiens
Tissue, cell type: colonic biopsy (male donor), colonic epithelial progenitor cells
Morphology:
epithelial morphology
Life span extension:
ectopic expression of hTERT and cdk-4

Quality: free from contaminations (bacteria incl. mycoplasma, fungi, HIV, HAV, HBV, HCV, Parvo-B19) and cross-contaminations

Morphology and expression of marker proteins

HCEC-1CT cell line shows the typical epithelial, cobblestone appearance and expression of characteristic, colonic epithelial markers such as A33, Mucin-1 as well as moderate expression of Villin in 2D differentiated cultures. Cell nuclei are counterstained with DAPI.

Cell-cell contacts in 3D spheroid culture

When grown as 3D spheroids, HCEC-1CT cells form multicellular organoid structures that stain positive for ZO1 demonstrating formation of cell-cell contacts. Cell nuclei are counterstained with DAPI.

FAQs

In vitro propagation

ColoUp (Evercyte, Cat# MHT-039)

DMEM (Gibco, Cat# 10566016)/M199 (Gibco, Cat# 31150022) (4+1)

2 % Cosmic Calf Serum (Hyclone, Cat# SH30087)

20 ng/ml EGF (Sigma Aldrich, Cat# E9644)

10 µg/ml Insulin (Sigma Aldrich, Cat# I9278)

2 µg/ml Apo-Transferrin (Sigma Aldrich, Cat# T2036)

5 nM Sodium-Selenit (Sigma-Aldrich, Cat# S5261)

1 µg/ml Hydrocortisone (Sigma Aldrich, Cat# H0396)

Additional material & reagents

Phosphate buffered saline (PBS) (Sigma, Cat# D8537)

Trypsin inhibitor (Gibco, Cat# R007100)

0,05 % Trypsin-EDTA (Gibco, Cat#25300-054)

Protocol passaging of HCEC-1CT
 
Passaging of cells

For detachment of the cells remove and discard the culture medium and wash the cells once with PBS (about 160 µl/cm²). Remove PBS completely.

Then, add 0.05 % Trypsin-EDTA solution (20 µl/cm²), make sure that all cells have been in contact with this solution and incubate the culture flask at 37°C for approximately 2-3 min.
Observe cell detachment under an inverted microscope. As soon as all cells are detached (if necessary, agitate the cells by gently hitting the flask), add Trypsin-Inhibitor (20 µl/cm²).
Thereafter, resuspend the cells in growth medium (about 160 µl/cm²) and aspirate the cells by pipetting, centrifuge at 170 g for 5 min.
A split ratio of 1:16 twice a week is recommended (after cells have reached about 85-95 % confluence). Perform a medium change after 2-3 days if cells have not reached required cell density.
Cultivate cells at 37°C in a humidified atmosphere with 5% CO2.

Cryopreservation

Freezing medium

ColoUp growth medium (Evercyte, Cat# MHT-039)

10% DMSO (Sigma Aldrich, Cat# D2650)

10% Cosmic Calf Serum (Hyclone, Cat# SH30087)

Additional material & reagents

Phosphate buffered saline (PBS) (Sigma, Cat# D8537)

0,05 % Trypsin-EDTA (Gibco, Cat# 25300-054)

Trypsin inhibitor (Gibco, Cat# R007100)

Protocol cryopreservation of HCEC-1CT
Freezing of cells

Detach the cells from the culture vessel by using Trypsin-EDTA and Trypsin-Inhibitor (Protocol passaging of HCEC-1CT).

Resuspend the detached cells in growth medium and centrifuge at 170 g for 5 min.
Discard the supernatant, resuspend the resulting cell pellet in the remaining droplet and add freezing medium (tempered to 4°C) to reach a cell density of about 1-2 x 106 cells/ml (for thawing in a 25 cm² culture flask).

Add 1 ml of this cell suspension to each pre-cooled cryovial and immediately transfer the cells to -80°C.

After 24 hours transfer the vials to the liquid nitrogen tank.
Thawing of cells

Original Evercyte cells are to be thawed in a T25 roux flask

Add 6 ml of complete growth medium to a 25 cm² culture flask and place it in the incubator for at least 30 min to allow the medium to reach its normal pH.
Take a vial of frozen cells, rinse it outside with Ethanol and pre-warm in the hand until one last piece of frozen cells is seen.
Then, immediately transfer the content of the vial to a 15 ml centrifugation tube pre-filled with 9 ml of medium pre-cooled to 4°C and centrifuge for 5 min at 170 g.

Discard the supernatant and resuspend the cell pellet in the remaining droplet.

Add 1 ml of the pre-warmed medium to the cells, transfer them to the prepared culture flask and incubate at 37°C in a suitable incubator.
Perform a medium change 24 hours after thawing. If the cells are already 80 % confluent at this point, they have to be passaged.
Protocol passaging of HCEC-1CT

Product data sheet – certificate of analysis

Product data sheet (PDS) download
Certificate of analysis
is available upon request | Please contact us indicating the respective LOT numbers

Protocols

Preparation of cell culture medium ColoUp
Protocol passaging of HCEC-1CT
Protocol cryopreservation of HCEC-1CT

Data on markers and functions

HCEC-1CT – morphology and expression of marker proteins
HCEC-1CT – 3D spheroid culture and ZO-1 staining

Safety documents

Coming soon.

 

Selected publications

Scavo MP, Rizzi F, Depalo N, Fanizza E, Ingrosso C, Curri ML, Giannelli G. A Possible Role of FZD10 Delivering Exosomes Derived from Colon Cancers Cell Lines in Inducing Activation of Epithelial-Mesenchymal Transition in Normal Colon Epithelial Cell Line. Int J Mol Sci. 2020 Sep 3;21(18):6705. https://pubmed.ncbi.nlm.nih.gov/32933173/

Woelflingseder L, Adam G, Marko D. Suppression of Trichothecene-Mediated Immune Response by the Fusarium Secondary Metabolite Butenolide in Human Colon Epithelial Cells. Front Nutr. 2020 Aug 6;7:127. https://pubmed.ncbi.nlm.nih.gov/32850941/
Granofszky N, Lang M, Khare V, Schmid G, Scharl T, Ferk F, Jimenez K, Knasmüller S, Campregher C, Gasche C. Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer. Carcinogenesis. 2018 Feb 9;39(2):146-157. https://pubmed.ncbi.nlm.nih.gov/ 29106440/
Warth B. et al (2016), Identification of a novel human deoxynivalenol metabolite enhancing proliferation of intestinal and urinary bladder cells. Sci Rep. 2016 Sep 23;6:33854. https://pubmed.ncbi.nlm.nih.gov/27659167/
Roig AI, Eskiocak U, Hight SK, Kim SB, Delgado O, Souza RF, Spechler SJ, Wright WE, Shay JW. (2010), Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology 138(3):1012-21. https://pubmed.ncbi.nlm.nih.gov/19962984/
List of publications

Licence Conditions

The business concept of Evercyte is to out-license telomerized cells to our customers. The license conditions depend on whether the contract partner is a for profit or a nonprofit organization and the intended use of the cells.

Nonprofit organizations

Evercyte grants licenses for an unlimited period to academic or nonprofit-organizations, whereby the use of Evercyte cell lines is restricted to research & development purposes and non-commercial use. The cells are not intended for human use.
The customers have to agree to the conditions described in our material transfer agreement as well as accept our general terms and conditions.
On time payment for unlimited use: EUR 1300

Profit organizations

Pharmaceutical – chemical – cosmetic industries
Evercyte grants licenses for commercial organizations, whereby we offer an initial testing phase for a flat fee that allows our customers to test our cells in their laboratories for a period of 6 months.
Thereafter, annual license fees fall due, depending on the cell line of interest. Besides offering cell lines for research & development purposes, we also have established cell factories that qualify for production of clinical grade extracellular vesicles for human application.
The customer has to agree to the conditions described in our license agreements.
Contract research organizations (CRO)
Evercyte grants licenses for contract research organizations, whereby we offer an initial testing phase for a flat fee that allows our customers to test our cells in their laboratories. Thereafter, we would negotiate a royalty based long-term license agreement individually.
The use of the cells during these phases is restricted to research & development purposes. The cells are not intended for human use. The customers have to agree to the conditions described in our material transfer agreement and accept our general terms and conditions.
Initial license fee for 6 months: EUR 2000
Annual license fee R&D: royalty based
Print Friendly, PDF & Email

from

€ 1300,–

HCEC-1CT
Cat#: CHT-039-0229

Ordering now

ONLY FOR NON PROFIT

Ordering

FOR PROFIT INDUSTRY

Ordering

FOR PROFIT-CRO

Related Products

ColoUp medium for growth of HCEC-1CT cells

read more

Related Services

send us specific request

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

all about
our cells

read more

interested in testing a drug on HCEC-1CT?

read more

all about
our exosomes

read more

news

Development of tumor targeting EVs

partnership between MDimune and Evercyte / April 2021

read more

Related Products

ColoUp MHT-039

Related Services

specific request

Customer Reviews

“I have had the pleasure of working with Evercyte for the last few years. We continually rely on Evercyte because of the high-quality data that they produce, their diligent responsiveness, and their excellent customer service.”

 

Josh Garlich, Senior Research Scientist, Apellis Pharmaceuticals, Inc.

“Cytonus has been working with Evercyte from many years as they are a trusted partner and have always delivered the highest quality cell lines to advance our platform.  We routinely draw on their expertise to meet cellular engineering challenges and they have not disappointed.”

Remo Moomiaie-Qajar, Cytonus Therapeutics, Inc.

Print Friendly, PDF & Email

from

€ 1300,–

HCEC-1CT
Cat#: CHT-039-0229

Ordering

ONLY FOR NON PROFIT

Ordering

FOR PROFIT INDUSTRY

Ordering

FOR PROFIT-CRO